Yatabe Y - Search Results

1

The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.

Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB, Goo JM, MacMahon H, Naidich D, Nicholson AG, Powell CA, Prokop M, Rami-Porta R, Rusch V, van Schil P, Yatabe Y; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and Advisory Board Members. Travis WD, et al. Among authors: yatabe y. J Thorac Oncol. 2016 Aug;11(8):1204-1223. doi: 10.1016/j.jtho.2016.03.025. Epub 2016 Apr 21. J Thorac Oncol. 2016. PMID: 27107787 Free article. Review.

2

Increased expression of COX-2 in the development of human lung cancers.

Takahashi T, Kozaki K, Yatabe Y, Achiwa H, Hida T. Takahashi T, et al. Among authors: yatabe y. J Environ Pathol Toxicol Oncol. 2002;21(2):177-81. J Environ Pathol Toxicol Oncol. 2002. PMID: 12086404

3

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Endoh H, et al. Among authors: yatabe y. Int J Cancer. 2003 Aug 10;106(1):45-51. doi: 10.1002/ijc.11184. Int J Cancer. 2003. PMID: 12794755 Free article.

4

Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients.

Osada H, Tatematsu Y, Saito H, Yatabe Y, Mitsudomi T, Takahashi T. Osada H, et al. Among authors: yatabe y. Int J Cancer. 2004 Oct 20;112(1):26-32. doi: 10.1002/ijc.20395. Int J Cancer. 2004. PMID: 15305372 Free article.

5

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Kosaka T, et al. Among authors: yatabe y. Cancer Res. 2004 Dec 15;64(24):8919-23. doi: 10.1158/0008-5472.CAN-04-2818. Cancer Res. 2004. PMID: 15604253

6

PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients.

Endoh H, Yatabe Y, Kosaka T, Kuwano H, Mitsudomi T. Endoh H, et al. Among authors: yatabe y. J Thorac Oncol. 2006 Sep;1(7):629-34. J Thorac Oncol. 2006. PMID: 17409929 Free article.

7

Prospective validation for prediction of gefitinib sensitivity by epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer.

Yoshida K, Yatabe Y, Park JY, Shimizu J, Horio Y, Matsuo K, Kosaka T, Mitsudomi T, Hida T. Yoshida K, et al. Among authors: yatabe y. J Thorac Oncol. 2007 Jan;2(1):22-8. J Thorac Oncol. 2007. PMID: 17410005 Free article. Clinical Trial.

8

Controversy about small peripheral lung adenocarcinomas: how should we manage them?

Fukui T, Sakakura N, Mori S, Hatooka S, Shinoda M, Yatabe Y, Mitsudomi T. Fukui T, et al. Among authors: yatabe y. J Thorac Oncol. 2007 Jun;2(6):546-52. doi: 10.1097/JTO.0b013e318060d30d. J Thorac Oncol. 2007. PMID: 17545852 Free article. Review.

9

LKB1 gene mutations in Japanese lung cancer patients.

Onozato R, Kosaka T, Achiwa H, Kuwano H, Takahashi T, Yatabe Y, Mitsudomi T. Onozato R, et al. Among authors: yatabe y. Cancer Sci. 2007 Nov;98(11):1747-51. doi: 10.1111/j.1349-7006.2007.00585.x. Epub 2007 Aug 16. Cancer Sci. 2007. PMID: 17711506 Free article.

10

Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer.

Yatabe Y, Takahashi T, Mitsudomi T. Yatabe Y, et al. Cancer Res. 2008 Apr 1;68(7):2106-11. doi: 10.1158/0008-5472.CAN-07-5211. Cancer Res. 2008. PMID: 18381415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

743 results

Search Page